Ning Wen
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Ning Wen has a total of 699 co-authors. Here are the top co-authors by number of shared publications:
Indrin J. Chetty
Department of Radiation Oncology Henry Ford Health System Detroit Michigan USA
36 shared publicationsBenjamin Movsas
Department of Radiation Oncology Henry Ford Health System Detroit Michigan USA
26 shared publicationsI Chetty
Henry Ford Health System, Detroit, MI
20 shared publicationsJinkoo Kim
Department of Radiation Oncology, Stony Brook University, NY, USA
14 shared publicationsJ Jin
Henry Ford Health System, Detroit, MI
13 shared publicationsB Movsas
Henry Ford Health System, West Bloomfield, MI
12 shared publications
Latest Publications
- Open Access
- 31 December 2025
- Published by Springer Nature in npj Digital Medicine
- Vol. 9 (1)
A clinically validated 3D deep learning approach for quantifying vascular invasion in pancreatic cancer
Vascular invasion assessment is critical for surgical planning in pancreatic ductal adenocarcinoma (PDAC). Current CT-based assessments often rely on radiologists’ subjective 2D interpretations, which may not capture the continuous, three-dimensional tumor–vessel interactions and multiple vessel involvement, both essential for accurate preoperative evaluation. PAN-VIQ (Pancreatic Vascular Invasion Quantifier) is an automated deep learning framework to quantify tumor–vessel interactions from contrast-enhanced CT scans. It enables segmentation of pancreatic tumors and five critical vessels: celiac artery (CA), common hepatic artery (CHA), superior mesenteric artery (SMA), superior mesenteric vein (SMV), and portal vein (PV), quantifying vascular involvement through 3D encasement angles. PAN-VIQ was trained and internally validated on 2130 cases, and subsequently prospectively tested in 202 patients. External validation showed accuracies exceeding 90%. In prospective evaluation, the model outperformed junior radiologists and matched senior radiologists in accuracy and recall. These results underscore potential of PAN-VIQ to standardize vascular invasion assessment and reduce interobserver variability.
- 31 December 2025
- Published by Springer Nature in npj Digital Medicine
- Vol. 9 (1)
Open AccessA clinically validated 3D deep learning approach for quantifying vascular invasion in pancreatic cancer
Vascular invasion assessment is critical for surgical planning in pancreatic ductal adenocarcinoma (PDAC). Current CT-based assessments often rely on radiologists’ subjective 2D interpretations, which may not capture the continuous, three-dimensional tumor–vessel interactions and multiple vessel involvement, both essential for accurate preoperative evaluation. PAN-VIQ (Pancreatic Vascular Invasion Quantifier) is an automated deep learning framework to quantify tumor–vessel interactions from contrast-enhanced CT scans. It enables segmentation of pancreatic tumors and five critical vessels: celiac artery (CA), common hepatic artery (CHA), superior mesenteric artery (SMA), superior mesenteric vein (SMV), and portal vein (PV), quantifying vascular involvement through 3D encasement angles. PAN-VIQ was trained and internally validated on 2130 cases, and subsequently prospectively tested in 202 patients. External validation showed accuracies exceeding 90%. In prospective evaluation, the model outperformed junior radiologists and matched senior radiologists in accuracy and recall. These results underscore potential of PAN-VIQ to standardize vascular invasion assessment and reduce interobserver variability.
- Open Access
- 22 November 2025
- Published by Wiley
Daily Home FeNO Monitoring to Predict Response to Dupilumab in Severe Asthma: A Proof-of-Concept Study
- 22 November 2025
- Published by Wiley
Open AccessDaily Home FeNO Monitoring to Predict Response to Dupilumab in Severe Asthma: A Proof-of-Concept Study
- Open Access
- 18 November 2025
- Published by Elsevier in Cell Reports Medicine
- Vol. 6 (11) , 102452
A prognostic index integrating deep learning baseline PET/CT biomarkers and multi-omics profiling in diffuse large B cell lymphoma
- 18 November 2025
- Published by Elsevier in Cell Reports Medicine
- Vol. 6 (11) , 102452
Open AccessA prognostic index integrating deep learning baseline PET/CT biomarkers and multi-omics profiling in diffuse large B cell lymphoma
- Open Access
- 4 April 2025
- Published by Springer Nature in European Journal of Nuclear Medicine and Molecular Imaging
- Vol. 52 (10) , 3792-3806
Hypermetabolic pulmonary lesions detection and diagnosis based on PET/CT imaging and deep learning models
Purpose This study aims to develop and evaluate deep learning models for the detection and classification of hypermetabolic lung lesions into four categories: benign, lung cancer, pulmonary lymphoma, and metastasis. These categories are defined by their pathological origin, clinical relevance, and therapeutic implications. Methods A lesion localisation model was first developed using manually annotated PET/CT images. For classification, a multi-dimensional joint network was employed, incorporating both image patches and two-dimensional projections. Classification performance was quantified by metrics like accuracy, and compared to that of a radiomics model. Additionally, false-positive segmentations were manually reviewed and analysed for clinical evaluation. Results The study retrospectively included 647 cases (409 males/238 females) over more than 8 years from five centres, divided into an internal dataset (426 cases from Shanghai Ruijin Hospital), an external test set I (151 cases from four other institutions), and an external test set II (70 cases from a new imaging device). The localisation model achieved detection rates of 81.19%, 75.48%, and 77.59% on the internal, external test set I, and external test set II, respectively. The classification model outperformed the radiomics approach, with area-under-curves of 88.4%, 80.7%, and 66.6%, respectively. Most false-positive segmentations were clinically acceptable, corresponding to suspicious lesions in adjacent regions, particularly lymph nodes. Conclusion Deep learning models based on PET/CT imaging can effectively detect, segment, and classify hypermetabolic lung lesions, and identify suspicious adjacent lesions. These results highlight the potential of artificial intelligence in clinical decision-making and lung disease diagnosis. Graphical Abstract
- 4 April 2025
- Published by Springer Nature in European Journal of Nuclear Medicine and Molecular Imaging
- Vol. 52 (10) , 3792-3806
Open AccessHypermetabolic pulmonary lesions detection and diagnosis based on PET/CT imaging and deep learning models
Purpose This study aims to develop and evaluate deep learning models for the detection and classification of hypermetabolic lung lesions into four categories: benign, lung cancer, pulmonary lymphoma, and metastasis. These categories are defined by their pathological origin, clinical relevance, and therapeutic implications. Methods A lesion localisation model was first developed using manually annotated PET/CT images. For classification, a multi-dimensional joint network was employed, incorporating both image patches and two-dimensional projections. Classification performance was quantified by metrics like accuracy, and compared to that of a radiomics model. Additionally, false-positive segmentations were manually reviewed and analysed for clinical evaluation. Results The study retrospectively included 647 cases (409 males/238 females) over more than 8 years from five centres, divided into an internal dataset (426 cases from Shanghai Ruijin Hospital), an external test set I (151 cases from four other institutions), and an external test set II (70 cases from a new imaging device). The localisation model achieved detection rates of 81.19%, 75.48%, and 77.59% on the internal, external test set I, and external test set II, respectively. The classification model outperformed the radiomics approach, with area-under-curves of 88.4%, 80.7%, and 66.6%, respectively. Most false-positive segmentations were clinically acceptable, corresponding to suspicious lesions in adjacent regions, particularly lymph nodes. Conclusion Deep learning models based on PET/CT imaging can effectively detect, segment, and classify hypermetabolic lung lesions, and identify suspicious adjacent lesions. These results highlight the potential of artificial intelligence in clinical decision-making and lung disease diagnosis. Graphical Abstract
- Open Access
- 22 September 2023
- Published by Association for Computing Machinery (ACM)
- p. 273-279
Large Language Model Locally Fine-tuning (LLMLF) on Chinese Medical Imaging Reports
The emergence of large language models exerts significant impact in the field of natural language processing. These models, which are based on attention networks, have shown remarkable capabilities in understanding and generating human conversation context, surpassing most of the state-of-the-art models in Natural Language Processing (NLP). Though Generative Pre-trained GPT-series open their public Application Programming Interfaces (APIs) for direct inference, such services require users to upload (relinquish) their data to servers, thus not suitable for domains operating sensitive data, such as the medical field. Due to comparable smaller model size, existing local pre-trained model deployments are usually not that helpful on domain-specific data without further fine-tuning. In this paper, we leverage Microsoft’s recent open source DeepSpeed-Chat platform and one of our selected pre-trained models, to locally conduct fine-tuning on our medical imaging reports (in Chinese), to infer diagnosis recommendations based on the imaging description. Our output models show very promising results according to both NLP metrics and experts’ evaluation criteria. This paper provides an initial report on our latest progress on locally fine-tuning large language model for medical data.
- 22 September 2023
- Published by Association for Computing Machinery (ACM)
- p. 273-279
Open AccessLarge Language Model Locally Fine-tuning (LLMLF) on Chinese Medical Imaging Reports
The emergence of large language models exerts significant impact in the field of natural language processing. These models, which are based on attention networks, have shown remarkable capabilities in understanding and generating human conversation context, surpassing most of the state-of-the-art models in Natural Language Processing (NLP). Though Generative Pre-trained GPT-series open their public Application Programming Interfaces (APIs) for direct inference, such services require users to upload (relinquish) their data to servers, thus not suitable for domains operating sensitive data, such as the medical field. Due to comparable smaller model size, existing local pre-trained model deployments are usually not that helpful on domain-specific data without further fine-tuning. In this paper, we leverage Microsoft’s recent open source DeepSpeed-Chat platform and one of our selected pre-trained models, to locally conduct fine-tuning on our medical imaging reports (in Chinese), to infer diagnosis recommendations based on the imaging description. Our output models show very promising results according to both NLP metrics and experts’ evaluation criteria. This paper provides an initial report on our latest progress on locally fine-tuning large language model for medical data.
- Open Access
- 26 January 2023
- Published by Springer Nature in Nature Communications
- Vol. 14 (1) , 1-2
Author Correction: Federated learning enables big data for rare cancer boundary detection
- 26 January 2023
- Published by Springer Nature in Nature Communications
- Vol. 14 (1) , 1-2
Open AccessAuthor Correction: Federated learning enables big data for rare cancer boundary detection
- Top Cited PapersOpen Access
- 5 December 2022
- Published by Springer Nature in Nature Communications
- Vol. 13 (1) , 1-17
Federated learning enables big data for rare cancer boundary detection
Although machine learning (ML) has shown promise across disciplines, out-of-sample generalizability is concerning. This is currently addressed by sharing multi-site data, but such centralization is challenging/infeasible to scale due to various limitations. Federated ML (FL) provides an alternative paradigm for accurate and generalizable ML, by only sharing numerical model updates. Here we present the largest FL study to-date, involving data from 71 sites across 6 continents, to generate an automatic tumor boundary detector for the rare disease of glioblastoma, reporting the largest such dataset in the literature (n = 6, 314). We demonstrate a 33% delineation improvement for the surgically targetable tumor, and 23% for the complete tumor extent, over a publicly trained model. We anticipate our study to: 1) enable more healthcare studies informed by large diverse data, ensuring meaningful results for rare diseases and underrepresented populations, 2) facilitate further analyses for glioblastoma by releasing our consensus model, and 3) demonstrate the FL effectiveness at such scale and task-complexity as a paradigm shift for multi-site collaborations, alleviating the need for data-sharing.
- 5 December 2022
- Published by Springer Nature in Nature Communications
- Vol. 13 (1) , 1-17
Top Cited PapersOpen AccessFederated learning enables big data for rare cancer boundary detection
Although machine learning (ML) has shown promise across disciplines, out-of-sample generalizability is concerning. This is currently addressed by sharing multi-site data, but such centralization is challenging/infeasible to scale due to various limitations. Federated ML (FL) provides an alternative paradigm for accurate and generalizable ML, by only sharing numerical model updates. Here we present the largest FL study to-date, involving data from 71 sites across 6 continents, to generate an automatic tumor boundary detector for the rare disease of glioblastoma, reporting the largest such dataset in the literature (n = 6, 314). We demonstrate a 33% delineation improvement for the surgically targetable tumor, and 23% for the complete tumor extent, over a publicly trained model. We anticipate our study to: 1) enable more healthcare studies informed by large diverse data, ensuring meaningful results for rare diseases and underrepresented populations, 2) facilitate further analyses for glioblastoma by releasing our consensus model, and 3) demonstrate the FL effectiveness at such scale and task-complexity as a paradigm shift for multi-site collaborations, alleviating the need for data-sharing.
- 11 November 2022
- Published by IOP Publishing in Physics in Medicine & Biology
- Vol. 67 (22) , 22TR02
Deep reinforcement learning and its applications in medical imaging and radiation therapy: a survey
Reinforcement learning takes sequential decision-making approaches by learning the policy through trial and error based on interaction with the environment. Combining deep learning and reinforcement learning can empower the agent to learn the interactions and the distribution of rewards from state-action pairs to achieve effective and efficient solutions in more complex and dynamic environments. Deep reinforcement learning (DRL) has demonstrated astonishing performance in surpassing the human-level performance in the game domain and many other simulated environments. This paper introduces the basics of reinforcement learning and reviews various categories of DRL algorithms and DRL models developed for medical image analysis and radiation treatment planning optimization. We will also discuss the current challenges of DRL and approaches proposed to make DRL more generalizable and robust in a real-world environment. DRL algorithms, by fostering the designs of the reward function, agents interactions and environment models, can resolve the challenges from scarce and heterogeneous annotated medical image data, which has been a major obstacle to implementing deep learning models in the clinic. DRL is an active research area with enormous potential to improve deep learning applications in medical imaging and radiation therapy planning.
- 11 November 2022
- Published by IOP Publishing in Physics in Medicine & Biology
- Vol. 67 (22) , 22TR02
Deep reinforcement learning and its applications in medical imaging and radiation therapy: a survey
Reinforcement learning takes sequential decision-making approaches by learning the policy through trial and error based on interaction with the environment. Combining deep learning and reinforcement learning can empower the agent to learn the interactions and the distribution of rewards from state-action pairs to achieve effective and efficient solutions in more complex and dynamic environments. Deep reinforcement learning (DRL) has demonstrated astonishing performance in surpassing the human-level performance in the game domain and many other simulated environments. This paper introduces the basics of reinforcement learning and reviews various categories of DRL algorithms and DRL models developed for medical image analysis and radiation treatment planning optimization. We will also discuss the current challenges of DRL and approaches proposed to make DRL more generalizable and robust in a real-world environment. DRL algorithms, by fostering the designs of the reward function, agents interactions and environment models, can resolve the challenges from scarce and heterogeneous annotated medical image data, which has been a major obstacle to implementing deep learning models in the clinic. DRL is an active research area with enormous potential to improve deep learning applications in medical imaging and radiation therapy planning.
- 22 July 2022
- Published by Springer Nature
- p. 239-248
Brain Tumor Segmentation Using Non-local Mask R-CNN and Single Model Ensemble
- 22 July 2022
- Published by Springer Nature
- p. 239-248
Brain Tumor Segmentation Using Non-local Mask R-CNN and Single Model Ensemble
- Open Access
- 19 April 2022
- Published by Wiley in Precision Radiation Oncology
- Vol. 6 (2) , 119-126
Magnetic resonance imaging‐only‐based radiation treatment planning for simultaneous integrated boost of multiparametric magnetic resonance imaging‐defined dominant intraprostatic lesions
- 19 April 2022
- Published by Wiley in Precision Radiation Oncology
- Vol. 6 (2) , 119-126
Open AccessMagnetic resonance imaging‐only‐based radiation treatment planning for simultaneous integrated boost of multiparametric magnetic resonance imaging‐defined dominant intraprostatic lesions